DermTech (DMTK) Tops Q4 EPS by 1c

DermTech (NASDAQ: DMTK) reported Q4 EPS of ($0.56), $0.01 better than the analyst estimate of ($0.57). Revenue for the quarter came in at $3.9 million versus the consensus estimate of $4.04 million.

For earnings history and earnings-related data on DermTech (DMTK) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Hydrofarm Holdings Group, Inc. (HYFM) Misses Q2 EPS by 134c
• JD.com (JD) Reiterated at Buy by Benchmark Amid Earnings Recovery